Earnings Proximity Warning
Earnings were reported on Jul 30, 2026. Post-earnings price action may still be settling.
Analyst vs AI Verdict
DIVERGENTWall Street
AI Expert Panel
Price Chart
Entry Reason
Drawdown 21% (within range) | Significant drawdown 21% | RSI oversold (50) | RSI turning up (49 → 50)
Entry Technical Conditions
Methodology →AI Expert Panel
STRONG_BUYThe stock has experienced a significant decline from over $134 in mid-2025 to the current $109.05 level, creating a compelling dip-buying entry point near multi-month lows with recent stabilization and a bounce off the $100-$102 support zone. Fundamentals remain solid with a low beta of 0.27 indicating defensive characteristics, strong ROE of 143.6%, healthy net margin of 12.8%, and an attractive 4.76% dividend yield that Jim Cramer has publicly endorsed at current levels. The recent acquisition of Kenvue is viewed positively by analysts as creating a higher-margin consumer powerhouse, and the company has reaffirmed its FY26 outlook while posting Q1 earnings growth. Key risks over the next 2-12 weeks include continued pressure on revenue growth (negative over 3- and 5-year periods), a current ratio below 1 signaling potential liquidity concerns, and broader consumer staples sector volatility amid economic uncertainty. Overall this presents a favorable swing-trade setup with estimated upside potential of 8-12% as the stock rebounds toward the $118-$122 resistance area within the specified horizon.
Kimberly-Clark is currently showing constructive price action, having established a solid support base near the $100-$105 level before recently pushing toward $110. The stock is exhibiting a pattern of higher lows, and the recent consolidation around $109 suggests it is building momentum for a potential breakout toward its previous resistance levels near $115-$116. Fundamentally, the company remains a stable consumer staple with a strong dividend yield of 4.76%, which provides a defensive floor for the stock during market volatility. Key risks over the 2-12 week horizon include broader market sector rotation away from consumer staples and potential sensitivity to interest rate fluctuations, but the current valuation and recent positive news regarding operational efficiency support a bullish outlook. I estimate an upside potential of 5-7% within the next 8 weeks as the stock tests its recent highs.
KMB is currently at $109.05, near the upper end of its recent trading range (92-116 over the past year), which limits immediate upside potential for a 2-12 week swing trade. The price action shows a volatile, range-bound pattern with no clear breakout momentum—the stock has repeatedly failed to sustain moves above $110-115 and has pulled back sharply multiple times, most recently from $115.47 in late July to $107.56 currently. Fundamentally, while the company shows strong profitability metrics (ROE 143.6%, P/E 17.4, 4.76% dividend yield) and recent positive news about the Kenvue acquisition, the underlying business faces headwinds: 3-year and 5-year revenue growth are both negative (-6.6% and -3.0% respectively), the current ratio of 0.77 indicates tight liquidity, and the extremely high P/B ratio of 22.29 suggests the stock is richly valued relative to book value. Key risks on the 2-12 week horizon include consumer spending weakness in a mature market, potential dividend pressure if earnings deteriorate, and the stock's low beta (0.27) indicating it lacks the volatility needed for profitable swing trading. For a speculative swing trade requiring 15-25% upside potential, KMB's current valuation, lack of clear breakout setup, and negative revenue trends make this an unattractive entry point—better to wait for a pullback to $100-102 or a clear technical breakout above $115 with volume confirmation.
Price action: The stock has rebounded from a June low near 97 to about 109 recently, placing it in an ongoing uptrend; buying now is reasonable if you expect continuation, with a potential push toward 110-112 on a break of near-term resistance, which could open a path to 115-118 over 2-12 weeks. Fundamental health: KMB offers a defensive profile with a ~4.8% dividend yield and a reasonable P/E around 17.4, but revenue growth has been negative over 3-5 years and liquidity is tight (current ratio 0.77) with a notably high P/B, suggesting valuation and balance-sheet risks despite earnings momentum. Key risks: In 2-12 weeks, a softer consumer environment, input-cost pressure, or a weaker-than-expected quarter could curb upside; the long-run negative revenue trend and balance-sheet signals warrant caution about sustained multiple expansion. Final verdict with upside potential: If the uptrend persists and 110-112 is cleared on strong volume, the stock could reach 115-118 within the horizon, implying roughly 6-11% upside from 109; use a stop near 105-106 to limit downside in case of a reversal.
Fundamentals Trend
| Metric | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 | 2026-08-04 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 216.1% | 216.1% | 173.3% | 173.3% | 173.3% | 143.6% |
| P/E (TTM) | 18.22 | 16.86 | 20.17 | 18.05 | 17.00 | 17.42 |
| Net Margin | 12.9% | 12.9% | 10.9% | 10.9% | 10.9% | 12.8% |
| Gross Margin | 36.5% | 36.5% | 36.3% | 36.5% | 36.5% | 37.1% |
| D/E Ratio | 572.62 | 572.62 | 551.13 | 551.13 | 551.13 | — |
| Current Ratio | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 |
More Signals for KMB
View all →Related News
View all →Jim Cramer Says Kimberly-Clark’s Acquisition of Kenvue Creates a High-Margin Powerhouse
Kimberly-Clark vs. The Clorox: Which Consumer Goods Stock Is a Better Buy in 2026?
Market Update: CVS, ETN, KMB, KO, PSX
SDY, O, KVUE, KMB: Large Outflows Detected at ETF
Kimberly-Clark Reaffirms FY26 Outlook - Update
Quality Checks
Signal Info
Disclaimer: This is an automated trading signal generated by AI analysis. It is not financial advice. Always do your own research before making investment decisions. Past performance does not guarantee future results.